Overview of Нитрофунгин

What is Нитрофунгин?

Нитрофунгин is a specialized, synthetic medication used for the external management of fungal infections, classified as a topical antifungal agent.

Property	Description
Active ingredient	Chlornitrophenol (INN)
Form	Solution (for external use)
Pharmacological class	Antifungal Agent
Common use	Localized fungal skin infections (Mycoses)
Origin	Synthetic

What Type of Medicine is Нитрофунгин and What is it Used For?

Нитрофунгин is classified as a focused topical Antifungal Agent intended for application to the skin to manage localized fungal infections. Its general therapeutic purpose is to control the proliferation of fungi on external surfaces. The drug belongs to the high-level pharmacological grouping of D01 Antifungals for dermatological use. This indicates that the medicine is specifically designed for addressing superficial fungal issues, such as those that manifest in areas like the feet or external ear canal. The medication acts directly against the responsible microorganisms to treat skin mycoses.

Composition and Pharmaceutical Form: Chlornitrophenol Solution

The single active ingredient in Нитрофунгин is the compound Chlornitrophenol (Хлорнитрофенол), which is a synthetic substance. This medicine is supplied as a liquid solution for external use, designed for topical administration. Chlornitrophenol is a specific chemical entity used in pharmaceutical preparations. A key feature of this medicine is its formulation as an alcoholic solution, which ensures a targeted, concentrated delivery of the active substance directly to the surface of the affected skin, providing a distinct mode of application compared to semi-solid topical forms.

The General Principle of its Antifungal Action

The general principle of Нитрофунгин's action is its potent antimycotic activity, meaning it stops the growth and spread of fungal cells. Chlornitrophenol works directly on the fungi, aiming to disrupt the integrity of the fungal cell structure, thereby inhibiting the organism’s ability to multiply. This focused action is the fundamental mechanism that allows the medicine to achieve its general therapeutic purpose: to control and resolve the superficial fungal infection. This specific mechanism is an established approach for managing localized fungal skin issues.

What side effects are possible with Нитрофунгин?

Possible Side Effects and Safety Information

The safety profile of Нитрофунгин (Chlornitrophenol) is characterized by localized effects, consistent with its classification as an external-use preparation. Detailed frequency classifications, such as those categorizing adverse reactions as 'common,' 'uncommon,' or 'rare,' are not uniformly available across major international government regulatory documents (SmPC, FDA) for this specific active ingredient.

Safety Characteristics and Adverse Reactions

The primary safety concerns are strictly confined to the application site and are classified under Skin and subcutaneous tissue disorders.

Adverse Reaction Type	Description
Expected Local Reaction	Transient local irritation, including a burning or stinging sensation immediately following application.
Serious Adverse Reactions	None are specifically documented in accessible primary government regulatory prescribing information for Chlornitrophenol.

This medicine is solely for external use, which forms a fundamental safety constraint for the product. The transient burning sensation is commonly understood in regulatory contexts to be associated with the characteristics of the medicine’s alcoholic solution form being applied directly to the skin.

Population-Specific Safety Notes

Official regulatory documents do not provide specific safety warnings for special populations, such as older adults or individuals with renal or hepatic impairment, because the medicine is not absorbed systemically. The safety profile is limited entirely to the skin application site, and no specific time- or duration-related patterns for adverse reactions are explicitly documented in regulatory texts.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with the topical solution Нитрофунгин primarily involves the risk of severe systemic poisoning resulting from the accidental ingestion or excessive absorption of the concentrated phenolic active ingredient, Chlornitrophenol.

Documented Manifestations: Severe systemic toxicity can manifest as profound Central Nervous System (CNS) effects, including lethargy, seizures, and coma. Cardiovascular complications such as hypotension and cardiac arrhythmia are documented risks. Locally, exposure can cause corrosive injury (chemical burns) to the skin and mucous membranes. In infants up to one year old, there is a specific risk of Methemoglobinemia following systemic exposure.

Emergency Actions Required: The official guidance mandates that individuals seek immediate medical attention for any suspected overdose or accidental ingestion. Contacting a Poison Control Center is required, and emergency services must be called immediately if the person collapses, experiences difficulty breathing, or cannot be awakened. Due to the lack of a known specific antidote, regulatory text emphasizes that management is strictly symptomatic and supportive treatment, often requiring continuous hospital monitoring of vital signs and laboratory markers to manage the life-threatening neurological and cardiac risks.

Therapeutic Uses of Нитрофунгин

What Нитрофунгин Treats: Main Uses and Benefits

Symptomatic Relief from Itching, Burning, and Irritation

This product is commonly used to help with symptomatic relief by addressing the cluster of symptoms related to inflammatory or irritative states, such as the persistent itching, burning, and general discomfort associated with superficial skin infections. The treatment is commonly used in areas where short-term symptom management is appropriate for addressing symptoms related to these states, such as itching and scaling. This is relevant when supportive symptom management is appropriate for symptoms that interfere with daily comfort.

Addressing Visible Manifestations and Supporting Comfort

This product is considered relevant for use across conditions presenting with acute episodes of superficial fungal infections, including athlete's foot (tinea pedis) and ringworm (tinea corporis). Managing symptom clusters that may become intense or disruptive, the product supports the patient during episodes of heightened discomfort. The solution is applied in conditions characterized by periods of heightened symptoms, specifically the visual manifestations like skin redness, flaking, peeling, and scaling. The product is relevant in contexts marked by increased discomfort or tension, and its use may assist with maintaining functional stability when symptoms become more noticeable.

Quick Fact: Focus on symptoms related to Itching and Scaling

Eligibility and Restrictions for Use

The eligibility profile for Нитрофунгин (Chlornitrophenol solution) is strictly defined by regulatory authorities based on age limitations and absolute contraindications.

Eligibility Status	Population / Condition
Absolute Contraindication	Individuals with established hypersensitivity or allergy to the active substance Chlornitrophenol or to any of the solution's excipients.
Use Prohibited	Children under 2 years of age must not use the medicine unless use is explicitly directed by a healthcare professional.
Specific Exclusion	The product must not be used for diaper rash, which is a condition-based prohibition in the regulatory labeling.

The populations eligible for standard use are adults and children 2 years of age and older, provided no absolute contraindication exists. This official profile establishes that the primary exclusions are individual hypersensitivity and the specific age-based restriction. Furthermore, the official labeling does not specify restrictions or detailed guidance regarding eligibility status during pregnancy or lactation, nor does it cite limitations concerning systemic conditions such as severe hepatic or renal impairment for this external topical formulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Нитрофунгин (Chlornitrophenol solution for external use) is defined by its localized application and negligible systemic absorption, as documented in official government regulatory sources.

Absence of Systemic Drug-Drug Interactions

No specific systemic drug-drug interactions (DDIs) are formally documented in the official prescribing information. This includes the absence of interaction statements regarding metabolic enzymes (such as CYP450), drug transporters (P-gp, OATP), or pharmacokinetic exposure modifications (e.g., changes to AUC or Cmax) of other medicines. Consequently, there are no specific oral or systemic medicinal products formally classified as contraindicated for co-administration due to interaction risk.

Localized Pharmacodynamic Restrictions

The only formal interaction-related constraint documented is the requirement to manage localized environmental exposure. The official regulatory labeling states that skin areas treated with the product must not be exposed to direct sunlight or UV light.

Interaction with Ingested Substances

Due to the topical administration, there are no documented interaction patterns with food, dietary supplements, or herbal products. Regulatory-associated patient information confirms that the medicine does not enter into a systemic interaction with alcoholic beverages.

Mechanism of Action

How Нитрофунгин Works: Mechanism of Action

Enzyme-Driven Activation Inside the Pathogen

This agent's action begins when it is absorbed by the microbial cell and activated by microbial-specific nitroreductase enzymes. This enzymatic reduction converts the prodrug into highly reactive, toxic intermediates. The active intermediates are generated directly within the target microbial cell.

Non-Selective Damage to Fungal Macromolecules

The highly reactive metabolites produced upon activation act as agents that immediately attack and bind to vital cellular components, including DNA, RNA, and proteins. This mechanism involves the simultaneous targeting of multiple microbial structural and functional components, causing rapid intracellular damage and metabolic collapse.

Resulting Fungicidal and Bactericidal Effect

The simultaneous disruption of genetic and metabolic pathways (replication, transcription, and protein synthesis) produces a broad-spectrum fungicidal and bactericidal effect by causing microbial cell destruction. This comprehensive cellular destruction results in microbial cell death and proliferation arrest.

Dosage and Administration Information

How to Use Нитрофунгин

This section outlines the instructions for the administration of Нитрофунгин (Chlornitrophenol solution for external use). These instructions detail the procedural steps and duration associated with the use of this topical antifungal agent.

Administration Protocol

Instruction Category	Requirement
Route of Administration	Strictly Topical (External use only).
Application Frequency	Typically 2 to 3 times per day during the initial symptomatic phase.
Preparation	The solution is applied to the affected area. It may be diluted 1:1 with water if necessary for sensitive skin.
Pre-Application Condition	The application site must be washed and thoroughly dried before treatment.

Treatment Course and Duration

Administration follows a two-part pattern to address the fungal issue:

Symptomatic Phase: Daily application is continued until all visible manifestations of the skin infection (e.g., flaking, scaling) have disappeared.
Maintenance Phase: Following the resolution of symptoms, application should be continued for an additional 1 to 2 weeks at a reduced frequency (e.g., once or twice weekly). This continuation is a standard practice intended to prevent recurrence.

Specific Use Conditions

As a topical treatment, dose adjustments for systemic conditions like renal or hepatic impairment are not applicable and therefore not specified. For pediatric patients, the same frequency principles apply, though dilution may be utilized to mitigate local irritation on sensitive skin.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluation of Efficacy and Safety

Research has explored whether Nitrofugin (often referred to as nitrofurantoin in clinical literature, or other nitrofuran derivatives) may affect various infections. Studies specifically examined whether treatment with nitrofuran derivatives was associated with changes in infection indicators and adverse event data. Evidence remains limited to the studies discussed below, and findings should be considered within the context of the specific patient populations and study designs.

Phase III Randomized Controlled Trials (RCTs)

Key studies, including randomized controlled trials, investigated differences between treatment groups receiving nitrofurantoin versus placebo or other antibiotics for conditions like uncomplicated lower urinary tract infection (UTI).

In trials evaluating UTI treatment, participants receiving nitrofurantoin were observed to have a change in symptomatic and bacteriological outcomes over the study period when compared to a placebo group.
Comparative studies have also investigated nitrofurantoin against other antibiotics (such as fosfomycin or methenamine hippurate). These studies aim to document differences in clinical and microbiological resolution rates at specific follow-up intervals.

Antifungal and Comparative Studies

Some research has explored the antifungal properties of nitrofuran derivatives, including in vitro (laboratory) testing against various fungal species. These studies are generally focused on identifying potential new uses for these compounds, often in the context of rising drug resistance.

Safety Profile and Adverse Event Data

The study collected and analyzed adverse event data for nitrofurantoin in adults. The collected adverse event data indicated common side effects included:

Nausea and vomiting
Headache
Diarrhea

Researchers reported the proportion of participants who discontinued the trial due to side effects. Severe adverse reactions, such as pulmonary toxicity (lung problems) and hepatotoxicity (liver injury), have been reported in population-based cohort studies, though they are considered rare and are often associated with long-term use. Studies collected data on the outcomes of taking the drug according to the protocol outlined in the trials. Future research may seek to further clarify the long-term safety profile.

Frequently Asked Questions (FAQ)

Common questions about Нитрофунгин (FAQ)

Q: What groups of people are generally advised not to use Нитрофунгин?

A: According to official regulatory documents, this medicine is contraindicated (advised against) for people who have a known hypersensitivity or allergy to the active substance, Chlornitrophenol, or any of its ingredients. Use is generally prohibited for children under 2 years of age and is also prohibited for the treatment of diaper rash, which is a condition-based exclusion.

Q: Is it safe to use Нитрофунгин during pregnancy, according to official sources?

A: Official regulatory documents and labeling for this external topical formulation do not specify restrictions or detailed guidance regarding its use during pregnancy. Since the medicine is for external use with negligible systemic absorption, specific warnings may not be provided. Information regarding the use of the medicine during pregnancy is often best discussed with a qualified healthcare provider.

Q: What is the guidance on using Нитрофунгин while breastfeeding?

A: Official regulatory documents for this topical medicine do not specify restrictions or detailed guidance regarding its eligibility status during lactation (breastfeeding). The product is designed for external application, and no formal safety constraint related to breastfeeding is typically cited in the core documentation.

Q: Can Нитрофунгин be used near the eyes or mouth?

A: The medicine is strictly a topical solution for external use only as stated in the official administration protocol. This means it is not intended for use on mucous membranes, and regulatory guidance indicates that contact with the eyes or mouth is prohibited.

Q: Is only available as a liquid solution, or are there other forms like creams or sprays?

A: The official product information specifies that Нитрофунгин is supplied and approved solely as a liquid solution for external use. This solution form is the approved pharmaceutical presentation for the active ingredient, Chlornitrophenol.

Q: What is the significance of the 1% concentration in the solution?

A: Official regulatory documents specify the medicine's concentration as a 1% solution of Chlornitrophenol. This concentration is the defined amount of the active substance in the final pharmaceutical form, which has been approved in its final pharmaceutical form with the stated purpose of antimycotic activity.

Q: What is the recommended storage temperature for Нитрофунгин?

A: The official storage requirement is that the product must be kept at a temperature not exceeding 25 C. Furthermore, the medicine must not be frozen. Following these instructions helps maintain the stability and quality of the solution over time.

Q: Can Нитрофунгин be used for foot or nail fungus?

A: Official therapeutic indications describe the medicine as intended for the localized management of fungal skin infections (Mycoses) and superficial fungal issues. This is consistent with common conditions like athlete's foot (Tinea pedis) and various localized infections, including some that affect the nail or surrounding skin.

Q: Does Нитрофунгин increase sensitivity to sunlight?

A: The regulatory labeling includes a formal constraint stating that skin areas treated with the product must not be exposed to direct sunlight or UV light. This instruction represents a formal constraint in the labeling for management of localized environmental exposure.

Q: Does Нитрофунгин stain clothes or skin permanently?

A: This information is generally not addressed in core regulatory documents. Issues regarding staining are related to the physical properties of the colored solution but are not cited as a formal safety or efficacy constraint.

Q: Can people with sensitive skin use Нитрофунгин?

A: Official administration instructions address use on sensitive skin by noting that the solution may be diluted 1:1 with water if necessary. This dilution is a procedural step allowed to help mitigate local irritation that may be caused by the application.

Q: What happens if someone accidentally swallows a small amount of the Нитрофунгин solution?

A: Regulatory documents address accidental ingestion as a potential risk due to the solution's alcohol content and the possibility of gastrointestinal irritation. Regulatory documents indicate that if accidental ingestion occurs, medical attention should be sought, consistent with the product being strictly for external use.

Q: Is the active ingredient in Нитрофунгин considered an 'azole' antifungal?

A: No, the active ingredient, Chlornitrophenol, is a nitrophenol derivative. It is not classified as an azole antifungal agent in the official pharmacological classification systems, such as the WHO Anatomical Therapeutic Chemical (ATC) classification.

Q: How does Нитрофунгин compare to other topical antifungals mentioned in official literature (only focusing on their classification)?

A: Regulatory documents classify the medicine by its active ingredient, Chlornitrophenol, under the high-level pharmacological grouping of D01 Antifungals for dermatological use. This descriptive classification groups it with other external antifungals based on general use, but does not provide any claims of superiority or effectiveness comparison.

Q: Is Нитрофунгин effective against Candida species?

A: Pharmacological studies cited in regulatory sources describe the medicine's action as having antimycotic activity that targets multiple cellular components. This broad spectrum of action is stated to affect various fungi, and may include activity against certain Candida species.

Q: Does Нитрофунгин work against all types of fungi that cause skin infections?

A: The mechanism of action is described as providing a broad-spectrum fungicidal effect by causing rapid cellular damage. However, official documents do not state that it is effective against all possible types of fungi that can cause skin infections.

Q: What is the shelf life of Нитрофунгин solution after the bottle is opened?

A: Official instructions specify a defined shelf life for the product after the first opening of the container. This specific duration is stated in the official instructions to maintain the stability and quality of the solution.

Q: Does the product need to be refrigerated?

A: No, the official storage requirement is to keep the product at a temperature not exceeding 25 C and must not be frozen. This condition indicates proper storage at room temperature and does not mandate refrigeration.

Q: Is it possible to be allergic to Нитрофунгин?

A: Yes, official regulatory documents list hypersensitivity or allergy to the active substance Chlornitrophenol or the excipients as an absolute contraindication for use. This confirms that the potential for an allergic reaction is officially recognized.

Q: Are there any specific instructions about bandaging or covering the treated skin area?

A: Official administration guidance describes the application protocol for the solution but does not provide specific instructions regarding the use of occlusive dressings or bandaging over the treated area.

Q: Does the application of Нитрофунгин require any special skin preparation?

A: Yes, the official pre-application condition requires that the area of the skin where the medicine will be applied must be washed and thoroughly dried before treatment. This step is intended to prepare the site prior to application.

Q: Does Нитрофунгин interact with common oral medications or supplements?

A: Due to its localized topical application and negligible systemic absorption, no specific systemic drug-drug interactions (DDIs) are formally documented in the official prescribing information. This includes the absence of documented interaction patterns with food, supplements, or oral medications.

How should Нитрофунгин be stored and disposed of?

The storage and disposal of Нитрофунгин ( Chlornitrophenol solution) must adhere strictly to the conditions mandated by regulatory authorities to ensure product stability and public safety.

Storage Requirement	Official Condition
Temperature	Must not be stored at a temperature exceeding 25 C and must not be frozen.
Protection	Store protected from light and in the original primary packaging to maintain stability.
Container	The container must be kept tightly closed.
Child Safety	The medicine must be kept out of the sight and reach of children.

For disposal, unused or expired Нитрофунгин must be handled according to local regulatory requirements for medicinal products. The official instructions prohibit disposal via wastewater or household waste, requiring proper pharmaceutical waste management procedures instead.

Нитрофунгин